Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-015822)

Filing Details

Accession Number:: 0000899243-20-015822
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-09 16:44:32
Reporting Period:: 2020-06-05

Accepted Time:: 2020-06-09 16:44:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1463361	Unity Biotechnology Inc.	UBX	Pharmaceutical Preparations (2834)	264726035

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1559531	E Nathaniel David	C/O Unity Biotechnology, Inc. 285 East Grand Avenue South San Francisco CA 94080	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2020-06-05	3,200	$8.90	2,327,186	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices vary between $8.8994 and $8.8995 per share. Information on the exact number of shares purchased at each purchase price can be obtained from Issuer upon request.
Includes Restricted Stock Units which vest over time measured from the grant date.